HORMONAL-REGULATION OF CA125 TUMOR-MARKER EXPRESSION IN HUMAN OVARIAN-CARCINOMA CELLS - INHIBITION BY GLUCOCORTICOIDS

被引：0
|
作者：
KARLAN, BY
AMIN, W
CASPER, SE
LITTLEFIELD, BA
机构：
[1] YALE UNIV, SCH MED, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, NEW HAVEN, CT 06510 USA
[2] YALE UNIV, SCH MED, YALE COMPREHENS CANC CTR, NEW HAVEN, CT 06510 USA
来源：
CANCER RESEARCH | 1988年 / 48卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3502 / 3506
页数：5
相关论文
共 50 条
  • [41] MONITORING PATIENTS WITH OVARIAN-CARCINOMA - THE RELATIONSHIP OF SERUM CA125 LEVELS TO CT SCANNING
    MOSKOVIC, E
    WILTSHAW, E
    BLAKE, P
    PARSONS, C
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1991, 1 (03) : 125 - 131
  • [42] THE DIAGNOSTIC VALIDITY OF THE TUMOR-MARKER CA-125 IN OVARIAN-CANCER PATIENTS
    SEVELDA, P
    SALZER, H
    DITTRICH, C
    PATEISKY, N
    SPONA, J
    TUMORDIAGNOSTIK & THERAPIE, 1987, 8 (03) : 115 - 120
  • [43] EXPERIENCES WITH CA-125, A TUMOR-MARKER FOR MALIGNANT EPITHELIAL OVARIAN-TUMORS
    CROMBACH, G
    ZIPPEL, HH
    WURZ, H
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1985, 45 (04) : 205 - 212
  • [44] CLINICAL-VALUE OF A NEW SERUM TUMOR-MARKER CA125-II, IN GYNECOLOGIC DISEASE - COMPARISON WITH CA125
    TAMAKOSHI, K
    KIKKAWA, F
    HASEGAWA, N
    ISHIKAWA, H
    MIZUNO, K
    KAWAI, M
    TOMODA, Y
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1995, 39 (02) : 125 - 129
  • [45] CA125 expression at clinical diagnosis by ovarian carcinoma not detected through antecedent serum CA125 screening
    Woolas, RP
    Oram, DH
    PrysDavies, A
    Leake, J
    Brown, CL
    Jacobs, IJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1996, 6 (02) : 98 - 101
  • [46] CA-125 - A NEW TUMOR-MARKER FOR OVARIAN GERM-CELL TUMORS
    ALTARAS, M
    GOLDBERG, GL
    BRITISH MEDICAL JOURNAL, 1985, 290 (6475): : 1112 - 1112
  • [47] TUMOR-MARKER ANTIGEN CA125 IN PANCREATIC-CANCER - A COMPARISON WITH CA19-9 AND CEA
    HAGLUND, C
    BRITISH JOURNAL OF CANCER, 1986, 54 (06) : 897 - 901
  • [48] The role of the ovarian tumor marker CA125 (MUC16) in the suppression of human immune responses
    Belisle, JA
    Arens, JA
    Migneault, M
    Rancourt, C
    Felder, M
    Connor, J
    Patankar, MS
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 635 - 636
  • [49] POSSIBILITIES AND LIMITS OF TUMOR-MARKER STUDIES IN THE FOLLOW-UP CARE OF OVARIAN-CARCINOMA PATIENTS
    KREIENBERG, R
    GYNAKOLOGE, 1986, 19 (03): : 178 - 185
  • [50] PERITONEAL-LAVAGE FLUID (PLF) CA125 - A TUMOR-MARKER AND INDEPENDENT PROGNOSTIC FACTOR IN EPITHELIAL OVARIAN-CANCER (EOC)
    REDMAN, CWE
    LUESLEY, DM
    BLACKLEDGE, G
    BUXTON, EJ
    CHAN, KK
    BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 460 - 460
12345